Trials / Unknown
UnknownNCT00243165
Lifemel Honey to Reduce Leucopenia During Chemotherapy
Lifemel Honey During Adjuvant Chemotherapy for Breast Cancer Patients to Prevent Leucopenia
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Rambam Health Care Campus · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will include 60 patients with early breast cancer referred to receive adjuvant chemotherapy with AC ( adriamycin- cyclophosphamide) or CAF ( adriamycin- cyclophosphamide- 5- fluorouracil ) combinations. These patients will receive every day one spoon of Lifemel honey or regular honey ( double blind)- during the adjuvant chemotherapy .Every week a WBC count will be performed in order to record the influence of Lifemel on myelotoxicity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Lifemel honey intake every day |
Timeline
- Start date
- 2005-11-01
- First posted
- 2005-10-21
- Last updated
- 2009-12-07
Source: ClinicalTrials.gov record NCT00243165. Inclusion in this directory is not an endorsement.